Trial Profile
A prospective study to evaluate the efficacy of Bevacizumab or Cetuximab combined with chemotherapy in patients with colorectal liver metastases
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 11 Apr 2016
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Cetuximab (Primary) ; Antineoplastics
- Indications Cancer metastases; Colorectal cancer
- Focus Therapeutic Use
- 11 Apr 2016 New trial record